2023年4月13日 · Increasing rebate transparency demands, growing generic equivalents, and anti-PBM sentiment among regulators created a perfect storm of threats to the ‘Big 3’s’ cash cows. By establishing PBM-led GPOs, they would ensure further rebate negotiation leverage over biopharma companies while adding revenue from GPO fees. In addition, firewalls ...

2022年7月12日 · In 2019, Express Scripts PBM (pharmacy benefit manager) formed Ascent Health Services GPO (group purchasing organization), based in Switzerland. In 2020, CVS Caremark formed Zinc GPO. And in 2021, OptumRx formed Emisar Pharma Services, based in …

As large pharmacy benefit managers (PBMs) create group purchasing organizations (GPOs) to manage the regulatory risk and transition to administrative fees as a source of revenue rather than manufacturer rebates, there is a lot of mystery surrounding the operation of these new entities.

2021年8月31日 · 药品集团采购组织（Group Purchasing Organization,GPO）是指医疗机构委托第三方中介组织，通过产品竞价等模式，获得比单一医院采购更低的价格，从而节约采购费用，即所谓的团购。 GPO与我国目前正在实施的国家带量采购的原理是一致的，即通过承诺用量，换取制药企业的降价。 这一政策将对医药商业企业的经营模式产生深远影响，长期来看，医药商业企业目前的经销商的模式将向配送商模式转型，即赚取差价的模式将变更为赚取配送费收入。 药品 …

PBMs serve third-party payers, including commercial insurance companies, government payers, and employer organizations in the retail/outpatient prescription arena, by negotiating supply and reimbursement arrangements for pharmaceuticals. GPOs do not take title to product, and neither GPOs nor PBMs function as distributors or wholesalers.

PBM reform can help improve patient access to therapy by reducing drug cost and eliminating mandatory use of PBM-owned mail-order, specialty and/or retail pharmacies. With two of the three big PBM GPOs being headquartered overseas, there’s a real concern that PBM rebate reform will …

2024年8月19日 · 器械与药品销售路径，医疗器械主要通过GPO （Group Purchasing Organization） 在院内使用，GPO与PBM业务路径不同，PBM主要侧重药品。在美国，前六大GPO控制了市场份额的50%以上，集中度虽不及PBM，但也相对集中。

With Precision’s Payer Master, finance and analytic teams can now connect rebate submissions and enrollment files from GPOs, PBMs, and health plans to other syndicated data sources, such as distribution, formulary coverage, covered lives, TRx, and claims, to create a rich, analytic-ready data set that can support complex market access use cases.

The threat rebate GPOs pose to manufacturers is the consolidation of rebate negotiation. When Prime Therapeutics and ESI/Cigna joined forces under Ascent, a behemoth representing approximately 30% of the PBM industry market was created. The deal also created a pathway which other small or mid-sized PBMs may be inclined to join.

pbm因其处方集优势，在药品流通过程中掌握核心议价权，同时随着混业经营的加深、pbm公司的高度集中，议价权进一步巩固深化 美国利用PBM和GPO手段，80%药品采购实现集采。